1. Home
  2. BIO vs EVR Comparison

BIO vs EVR Comparison

Compare BIO & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • EVR
  • Stock Information
  • Founded
  • BIO 1952
  • EVR 1995
  • Country
  • BIO United States
  • EVR United States
  • Employees
  • BIO N/A
  • EVR N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • EVR Investment Managers
  • Sector
  • BIO Industrials
  • EVR Finance
  • Exchange
  • BIO Nasdaq
  • EVR Nasdaq
  • Market Cap
  • BIO 6.0B
  • EVR 8.7B
  • IPO Year
  • BIO N/A
  • EVR 2006
  • Fundamental
  • Price
  • BIO $243.98
  • EVR $271.29
  • Analyst Decision
  • BIO Strong Buy
  • EVR Buy
  • Analyst Count
  • BIO 4
  • EVR 6
  • Target Price
  • BIO $324.25
  • EVR $254.00
  • AVG Volume (30 Days)
  • BIO 417.7K
  • EVR 538.3K
  • Earning Date
  • BIO 07-31-2025
  • EVR 07-23-2025
  • Dividend Yield
  • BIO N/A
  • EVR 1.25%
  • EPS Growth
  • BIO N/A
  • EVR 63.41
  • EPS
  • BIO N/A
  • EVR 10.47
  • Revenue
  • BIO $2,541,100,000.00
  • EVR $3,094,265,000.00
  • Revenue This Year
  • BIO N/A
  • EVR $7.34
  • Revenue Next Year
  • BIO $3.49
  • EVR $20.26
  • P/E Ratio
  • BIO N/A
  • EVR $25.68
  • Revenue Growth
  • BIO N/A
  • EVR 27.09
  • 52 Week Low
  • BIO $211.43
  • EVR $148.63
  • 52 Week High
  • BIO $387.99
  • EVR $324.06
  • Technical
  • Relative Strength Index (RSI)
  • BIO 60.94
  • EVR 71.72
  • Support Level
  • BIO $235.01
  • EVR $238.96
  • Resistance Level
  • BIO $246.50
  • EVR $276.68
  • Average True Range (ATR)
  • BIO 7.17
  • EVR 5.83
  • MACD
  • BIO 2.32
  • EVR 1.75
  • Stochastic Oscillator
  • BIO 90.49
  • EVR 86.02

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About EVR Evercore Inc.

Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,380 employees at the end of 2024, and about 75% of its revenue is derived from the United States.

Share on Social Networks: